We found that the RBM17 transcript level is significantly upregulated in the primitive cell subset (CD34+) as compared to the committed cell subset (CD34-) in OCI-AML-8227 cells (Supplementary Fig. 1c). Here, CD34 is linked to acute myeloid leukemia.